Venetoclax plus intensive chemotherapy with cladribine, idarubicin, and cytarabine in patients with newly diagnosed acute myeloid leukaemia or high-risk myelodysplastic syndrome: a cohort from a single-centre, single-arm, phase 2 trial.
暂无分享,去创建一个
M. Konopleva | H. Kantarjian | G. Garcia-Manero | T. Kadia | F. Ravandi | G. Borthakur | N. Daver | C. Dinardo | S. Kornblau | N. Pemmaraju | N. Jain | N. Short | Sa A. Wang | Y. Alvarado | P. Reville | R. Tidwell | R. Islam | M. Yilmaz